nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLC12A5—nerve—peripheral nervous system neoplasm	0.0194	0.166	CbGeAlD
Bumetanide—SLC12A5—ganglion—peripheral nervous system neoplasm	0.0192	0.164	CbGeAlD
Bumetanide—SLC12A1—ganglion—peripheral nervous system neoplasm	0.0092	0.0789	CbGeAlD
Bumetanide—SLC12A5—brainstem—peripheral nervous system neoplasm	0.00833	0.0714	CbGeAlD
Bumetanide—SLC12A4—brainstem—peripheral nervous system neoplasm	0.00692	0.0593	CbGeAlD
Bumetanide—SLC12A2—trigeminal ganglion—peripheral nervous system neoplasm	0.00539	0.0462	CbGeAlD
Bumetanide—SLC12A2—parotid gland—peripheral nervous system neoplasm	0.00509	0.0436	CbGeAlD
Bumetanide—CA4—nerve—peripheral nervous system neoplasm	0.00501	0.043	CbGeAlD
Bumetanide—CA4—ganglion—peripheral nervous system neoplasm	0.00495	0.0424	CbGeAlD
Bumetanide—SLC12A2—brainstem—peripheral nervous system neoplasm	0.00477	0.0409	CbGeAlD
Bumetanide—SLC12A5—cerebellum—peripheral nervous system neoplasm	0.00411	0.0352	CbGeAlD
Bumetanide—SLC12A4—cerebellum—peripheral nervous system neoplasm	0.00341	0.0292	CbGeAlD
Bumetanide—CA7—cerebellum—peripheral nervous system neoplasm	0.00264	0.0226	CbGeAlD
Bumetanide—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	0.00262	0.0225	CbGeAlD
Bumetanide—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.00262	0.00298	CcSEcCtD
Bumetanide—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00259	0.00296	CcSEcCtD
Bumetanide—Pancreatitis—Alitretinoin—peripheral nervous system neoplasm	0.00257	0.00293	CcSEcCtD
Bumetanide—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00251	0.00286	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.0025	0.00285	CcSEcCtD
Bumetanide—Hyperventilation—Doxorubicin—peripheral nervous system neoplasm	0.00246	0.0028	CcSEcCtD
Bumetanide—Blood creatinine increased—Cisplatin—peripheral nervous system neoplasm	0.00242	0.00276	CcSEcCtD
Bumetanide—Dehydration—Cisplatin—peripheral nervous system neoplasm	0.0024	0.00274	CcSEcCtD
Bumetanide—SLC12A2—cerebellum—peripheral nervous system neoplasm	0.00235	0.0202	CbGeAlD
Bumetanide—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.00235	0.00268	CcSEcCtD
Bumetanide—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00233	0.00266	CcSEcCtD
Bumetanide—Cramp muscle—Cisplatin—peripheral nervous system neoplasm	0.00232	0.00265	CcSEcCtD
Bumetanide—CA9—cerebellum—peripheral nervous system neoplasm	0.00232	0.0199	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00264	CcSEcCtD
Bumetanide—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.00262	CcSEcCtD
Bumetanide—CA4—parotid gland—peripheral nervous system neoplasm	0.00229	0.0197	CbGeAlD
Bumetanide—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.00225	0.00257	CcSEcCtD
Bumetanide—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00224	0.00255	CcSEcCtD
Bumetanide—CA14—cerebellum—peripheral nervous system neoplasm	0.0022	0.0188	CbGeAlD
Bumetanide—Pancreatitis—Cisplatin—peripheral nervous system neoplasm	0.00219	0.0025	CcSEcCtD
Bumetanide—Blood disorder—Epirubicin—peripheral nervous system neoplasm	0.00219	0.0025	CcSEcCtD
Bumetanide—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00217	0.00248	CcSEcCtD
Bumetanide—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.00217	0.00248	CcSEcCtD
Bumetanide—Sweating—Vincristine—peripheral nervous system neoplasm	0.00216	0.00246	CcSEcCtD
Bumetanide—CA4—brainstem—peripheral nervous system neoplasm	0.00215	0.0184	CbGeAlD
Bumetanide—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00214	0.00244	CcSEcCtD
Bumetanide—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00214	0.00244	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.00213	0.00243	CcSEcCtD
Bumetanide—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.00213	0.00243	CcSEcCtD
Bumetanide—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00213	0.00243	CcSEcCtD
Bumetanide—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00238	CcSEcCtD
Bumetanide—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00207	0.00236	CcSEcCtD
Bumetanide—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00207	0.00236	CcSEcCtD
Bumetanide—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.00234	CcSEcCtD
Bumetanide—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00205	0.00234	CcSEcCtD
Bumetanide—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.00234	CcSEcCtD
Bumetanide—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00205	0.00234	CcSEcCtD
Bumetanide—Blood disorder—Doxorubicin—peripheral nervous system neoplasm	0.00202	0.00231	CcSEcCtD
Bumetanide—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00202	0.00231	CcSEcCtD
Bumetanide—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.00201	0.00229	CcSEcCtD
Bumetanide—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.002	0.00229	CcSEcCtD
Bumetanide—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.002	0.00229	CcSEcCtD
Bumetanide—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00226	CcSEcCtD
Bumetanide—Hyperuricaemia—Epirubicin—peripheral nervous system neoplasm	0.00197	0.00225	CcSEcCtD
Bumetanide—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00223	CcSEcCtD
Bumetanide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00194	0.00221	CcSEcCtD
Bumetanide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00192	0.0022	CcSEcCtD
Bumetanide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00192	0.0022	CcSEcCtD
Bumetanide—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00192	0.00219	CcSEcCtD
Bumetanide—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.0019	0.00217	CcSEcCtD
Bumetanide—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.0019	0.00217	CcSEcCtD
Bumetanide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.0019	0.00217	CcSEcCtD
Bumetanide—Blood uric acid increased—Epirubicin—peripheral nervous system neoplasm	0.00186	0.00212	CcSEcCtD
Bumetanide—Musculoskeletal pain—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00211	CcSEcCtD
Bumetanide—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00184	0.0021	CcSEcCtD
Bumetanide—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.0021	CcSEcCtD
Bumetanide—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00208	CcSEcCtD
Bumetanide—Hyperuricaemia—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00208	CcSEcCtD
Bumetanide—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00181	0.00207	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00181	0.00206	CcSEcCtD
Bumetanide—Renal failure—Etoposide—peripheral nervous system neoplasm	0.00179	0.00204	CcSEcCtD
Bumetanide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00176	0.00201	CcSEcCtD
Bumetanide—Blood uric acid increased—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00196	CcSEcCtD
Bumetanide—Musculoskeletal pain—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00195	CcSEcCtD
Bumetanide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00171	0.00195	CcSEcCtD
Bumetanide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00193	CcSEcCtD
Bumetanide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00193	CcSEcCtD
Bumetanide—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00193	CcSEcCtD
Bumetanide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00167	0.00191	CcSEcCtD
Bumetanide—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00162	0.00185	CcSEcCtD
Bumetanide—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00183	CcSEcCtD
Bumetanide—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00183	CcSEcCtD
Bumetanide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00158	0.0018	CcSEcCtD
Bumetanide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00157	0.0018	CcSEcCtD
Bumetanide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00157	0.0018	CcSEcCtD
Bumetanide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00157	0.00179	CcSEcCtD
Bumetanide—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00157	0.00179	CcSEcCtD
Bumetanide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00178	CcSEcCtD
Bumetanide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00178	CcSEcCtD
Bumetanide—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00177	CcSEcCtD
Bumetanide—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00177	CcSEcCtD
Bumetanide—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.00177	CcSEcCtD
Bumetanide—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00155	0.00177	CcSEcCtD
Bumetanide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00155	0.00177	CcSEcCtD
Bumetanide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00154	0.00176	CcSEcCtD
Bumetanide—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00173	CcSEcCtD
Bumetanide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00149	0.00171	CcSEcCtD
Bumetanide—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	0.00149	0.0128	CbGeAlD
Bumetanide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00166	CcSEcCtD
Bumetanide—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00164	CcSEcCtD
Bumetanide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00142	0.00162	CcSEcCtD
Bumetanide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00141	0.00161	CcSEcCtD
Bumetanide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00141	0.00161	CcSEcCtD
Bumetanide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00141	0.0016	CcSEcCtD
Bumetanide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0014	0.0016	CcSEcCtD
Bumetanide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00159	CcSEcCtD
Bumetanide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00139	0.00159	CcSEcCtD
Bumetanide—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00159	CcSEcCtD
Bumetanide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00139	0.00159	CcSEcCtD
Bumetanide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00139	0.00159	CcSEcCtD
Bumetanide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00139	0.00158	CcSEcCtD
Bumetanide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00138	0.00158	CcSEcCtD
Bumetanide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00137	0.00157	CcSEcCtD
Bumetanide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00137	0.00156	CcSEcCtD
Bumetanide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00136	0.00155	CcSEcCtD
Bumetanide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00153	CcSEcCtD
Bumetanide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00153	CcSEcCtD
Bumetanide—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00134	0.00153	CcSEcCtD
Bumetanide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00152	CcSEcCtD
Bumetanide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00133	0.00151	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.0015	CcSEcCtD
Bumetanide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00131	0.00149	CcSEcCtD
Bumetanide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00148	CcSEcCtD
Bumetanide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00148	CcSEcCtD
Bumetanide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00147	CcSEcCtD
Bumetanide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00128	0.00146	CcSEcCtD
Bumetanide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00128	0.00145	CcSEcCtD
Bumetanide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00127	0.00145	CcSEcCtD
Bumetanide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00126	0.00144	CcSEcCtD
Bumetanide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00143	CcSEcCtD
Bumetanide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00143	CcSEcCtD
Bumetanide—Rash—Topotecan—peripheral nervous system neoplasm	0.00125	0.00143	CcSEcCtD
Bumetanide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00125	0.00142	CcSEcCtD
Bumetanide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00142	CcSEcCtD
Bumetanide—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00142	CcSEcCtD
Bumetanide—Headache—Topotecan—peripheral nervous system neoplasm	0.00124	0.00142	CcSEcCtD
Bumetanide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00141	CcSEcCtD
Bumetanide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00141	CcSEcCtD
Bumetanide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00141	CcSEcCtD
Bumetanide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00141	CcSEcCtD
Bumetanide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00124	0.00141	CcSEcCtD
Bumetanide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00123	0.00141	CcSEcCtD
Bumetanide—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00141	CcSEcCtD
Bumetanide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00141	CcSEcCtD
Bumetanide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00123	0.0014	CcSEcCtD
Bumetanide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00123	0.0014	CcSEcCtD
Bumetanide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00123	0.0014	CcSEcCtD
Bumetanide—Rash—Melphalan—peripheral nervous system neoplasm	0.00122	0.0014	CcSEcCtD
Bumetanide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00122	0.00139	CcSEcCtD
Bumetanide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00139	CcSEcCtD
Bumetanide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00121	0.00138	CcSEcCtD
Bumetanide—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00138	CcSEcCtD
Bumetanide—SLCO1A2—cerebellum—peripheral nervous system neoplasm	0.0012	0.0103	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00136	CcSEcCtD
Bumetanide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00135	CcSEcCtD
Bumetanide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00135	CcSEcCtD
Bumetanide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00134	CcSEcCtD
Bumetanide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00118	0.00134	CcSEcCtD
Bumetanide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00117	0.00134	CcSEcCtD
Bumetanide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00133	CcSEcCtD
Bumetanide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00133	CcSEcCtD
Bumetanide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00115	0.00131	CcSEcCtD
Bumetanide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00115	0.00131	CcSEcCtD
Bumetanide—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00131	CcSEcCtD
Bumetanide—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.0013	CcSEcCtD
Bumetanide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00114	0.0013	CcSEcCtD
Bumetanide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00113	0.00129	CcSEcCtD
Bumetanide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00112	0.00128	CcSEcCtD
Bumetanide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00128	CcSEcCtD
Bumetanide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00127	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00126	CcSEcCtD
Bumetanide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00125	CcSEcCtD
Bumetanide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00109	0.00124	CcSEcCtD
Bumetanide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00122	CcSEcCtD
Bumetanide—CA4—cerebellum—peripheral nervous system neoplasm	0.00106	0.00909	CbGeAlD
Bumetanide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.0012	CcSEcCtD
Bumetanide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00119	CcSEcCtD
Bumetanide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00118	CcSEcCtD
Bumetanide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00103	0.00117	CcSEcCtD
Bumetanide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00117	CcSEcCtD
Bumetanide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00116	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00116	CcSEcCtD
Bumetanide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00116	CcSEcCtD
Bumetanide—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.001	0.00115	CcSEcCtD
Bumetanide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.001	0.00114	CcSEcCtD
Bumetanide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000985	0.00112	CcSEcCtD
Bumetanide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000982	0.00112	CcSEcCtD
Bumetanide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00098	0.00112	CcSEcCtD
Bumetanide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000956	0.00109	CcSEcCtD
Bumetanide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000954	0.00109	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000951	0.00108	CcSEcCtD
Bumetanide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000949	0.00108	CcSEcCtD
Bumetanide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000947	0.00108	CcSEcCtD
Bumetanide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000939	0.00107	CcSEcCtD
Bumetanide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000938	0.00107	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000937	0.00107	CcSEcCtD
Bumetanide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.00106	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000929	0.00106	CcSEcCtD
Bumetanide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000924	0.00105	CcSEcCtD
Bumetanide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000919	0.00105	CcSEcCtD
Bumetanide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000912	0.00104	CcSEcCtD
Bumetanide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00091	0.00104	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000906	0.00103	CcSEcCtD
Bumetanide—Rash—Vincristine—peripheral nervous system neoplasm	0.000905	0.00103	CcSEcCtD
Bumetanide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000904	0.00103	CcSEcCtD
Bumetanide—Headache—Vincristine—peripheral nervous system neoplasm	0.000899	0.00103	CcSEcCtD
Bumetanide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000885	0.00101	CcSEcCtD
Bumetanide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000868	0.000991	CcSEcCtD
Bumetanide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000867	0.00099	CcSEcCtD
Bumetanide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000852	0.000973	CcSEcCtD
Bumetanide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000834	0.000952	CcSEcCtD
Bumetanide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000822	0.000938	CcSEcCtD
Bumetanide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000807	0.000921	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000802	0.000916	CcSEcCtD
Bumetanide—Rash—Cisplatin—peripheral nervous system neoplasm	0.0008	0.000913	CcSEcCtD
Bumetanide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000799	0.000912	CcSEcCtD
Bumetanide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000795	0.000908	CcSEcCtD
Bumetanide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000769	0.000877	CcSEcCtD
Bumetanide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000768	0.000876	CcSEcCtD
Bumetanide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000754	0.00086	CcSEcCtD
Bumetanide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000739	0.000843	CcSEcCtD
Bumetanide—Rash—Etoposide—peripheral nervous system neoplasm	0.000733	0.000836	CcSEcCtD
Bumetanide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000732	0.000836	CcSEcCtD
Bumetanide—Headache—Etoposide—peripheral nervous system neoplasm	0.000728	0.000831	CcSEcCtD
Bumetanide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000717	0.000819	CcSEcCtD
Bumetanide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000816	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00081	CcSEcCtD
Bumetanide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000691	0.000788	CcSEcCtD
Bumetanide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00068	0.000776	CcSEcCtD
Bumetanide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00068	0.000776	CcSEcCtD
Bumetanide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000665	0.000759	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.000757	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000755	CcSEcCtD
Bumetanide—PTGS2—cerebellum—peripheral nervous system neoplasm	0.00065	0.00557	CbGeAlD
Bumetanide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000728	CcSEcCtD
Bumetanide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00063	0.000719	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000718	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000718	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000615	0.000702	CcSEcCtD
Bumetanide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000695	CcSEcCtD
Bumetanide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.000674	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000665	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000643	CcSEcCtD
Bumetanide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000641	CcSEcCtD
Bumetanide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000533	0.000608	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000593	CcSEcCtD
Bumetanide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000591	CcSEcCtD
Bumetanide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000588	CcSEcCtD
Bumetanide—CFTR—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000497	0.0719	CbGpPWpGaD
Bumetanide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000563	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000547	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000544	CcSEcCtD
Bumetanide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000533	CcSEcCtD
Bumetanide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000526	CcSEcCtD
Bumetanide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000509	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000494	CcSEcCtD
Bumetanide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000492	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000487	CcSEcCtD
Bumetanide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000473	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000471	CcSEcCtD
Bumetanide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000469	CcSEcCtD
Bumetanide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000468	CcSEcCtD
Bumetanide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000466	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000455	CcSEcCtD
Bumetanide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000442	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000437	CcSEcCtD
Bumetanide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000434	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000433	CcSEcCtD
Bumetanide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000431	CcSEcCtD
Bumetanide—SLC10A1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000376	0.0544	CbGpPWpGaD
Bumetanide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000409	CcSEcCtD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000129	0.0187	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000129	0.0187	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000124	0.018	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000124	0.018	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000124	0.018	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000124	0.018	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—EED—peripheral nervous system neoplasm	0.000116	0.0168	CbGpPWpGaD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00011	0.0159	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000106	0.0153	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	9.79e-05	0.0142	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	9.49e-05	0.0137	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—SUZ12—peripheral nervous system neoplasm	9.26e-05	0.0134	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.13e-05	0.0118	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.61e-05	0.011	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.41e-05	0.0107	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.92e-05	0.01	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.92e-05	0.01	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.57e-05	0.00952	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.57e-05	0.00952	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.57e-05	0.00952	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.54e-05	0.00947	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.41e-05	0.00928	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.28e-05	0.00909	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	5.86e-05	0.00849	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.59e-05	0.00809	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.36e-05	0.00776	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.29e-05	0.00766	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.29e-05	0.00766	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.29e-05	0.00766	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.19e-05	0.00751	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.19e-05	0.00751	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.19e-05	0.00751	CbGpPWpGaD
Bumetanide—CA14—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.14e-05	0.00744	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.11e-05	0.0074	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.01e-05	0.00725	CbGpPWpGaD
Bumetanide—SLC22A7—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	4.75e-05	0.00687	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.68e-05	0.00677	CbGpPWpGaD
Bumetanide—CA7—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.68e-05	0.00677	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.5e-05	0.00651	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.41e-05	0.00639	CbGpPWpGaD
Bumetanide—CA12—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.33e-05	0.00627	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.13e-05	0.00598	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	4.06e-05	0.00588	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	4.01e-05	0.00581	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4e-05	0.00579	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.9e-05	0.00565	CbGpPWpGaD
Bumetanide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	3.83e-05	0.00555	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.75e-05	0.00543	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GNS—peripheral nervous system neoplasm	3.72e-05	0.00538	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GNS—peripheral nervous system neoplasm	3.62e-05	0.00524	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.62e-05	0.00524	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NME1—peripheral nervous system neoplasm	3.56e-05	0.00516	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.54e-05	0.00513	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NME1—peripheral nervous system neoplasm	3.47e-05	0.00503	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.45e-05	0.005	CbGpPWpGaD
Bumetanide—CA14—Metabolism—COX2—peripheral nervous system neoplasm	3.43e-05	0.00496	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.4e-05	0.00492	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GNS—peripheral nervous system neoplasm	3.38e-05	0.00489	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GNS—peripheral nervous system neoplasm	3.38e-05	0.00489	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—COX2—peripheral nervous system neoplasm	3.34e-05	0.00484	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.32e-05	0.00481	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NME1—peripheral nervous system neoplasm	3.24e-05	0.00469	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NME1—peripheral nervous system neoplasm	3.24e-05	0.00469	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GNS—peripheral nervous system neoplasm	3.13e-05	0.00453	CbGpPWpGaD
Bumetanide—CA7—Metabolism—COX2—peripheral nervous system neoplasm	3.12e-05	0.00452	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—COX2—peripheral nervous system neoplasm	3.12e-05	0.00452	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.01e-05	0.00436	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NME1—peripheral nervous system neoplasm	3e-05	0.00435	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.98e-05	0.00431	CbGpPWpGaD
Bumetanide—CA12—Metabolism—COX2—peripheral nervous system neoplasm	2.89e-05	0.00418	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.86e-05	0.00414	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.79e-05	0.00404	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.69e-05	0.0039	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.67e-05	0.00387	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.64e-05	0.00383	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.64e-05	0.00382	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.62e-05	0.0038	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GNS—peripheral nervous system neoplasm	2.62e-05	0.00379	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.54e-05	0.00367	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NME1—peripheral nervous system neoplasm	2.51e-05	0.00363	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GNS—peripheral nervous system neoplasm	2.5e-05	0.00362	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.48e-05	0.0036	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—COX2—peripheral nervous system neoplasm	2.42e-05	0.0035	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.42e-05	0.0035	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	2.41e-05	0.00349	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NME1—peripheral nervous system neoplasm	2.39e-05	0.00347	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	2.39e-05	0.00347	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.39e-05	0.00345	CbGpPWpGaD
Bumetanide—CA4—Metabolism—COX2—peripheral nervous system neoplasm	2.3e-05	0.00334	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ENO2—peripheral nervous system neoplasm	2.25e-05	0.00326	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ENO2—peripheral nervous system neoplasm	2.19e-05	0.00318	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	2.14e-05	0.0031	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ENO2—peripheral nervous system neoplasm	2.05e-05	0.00296	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ENO2—peripheral nervous system neoplasm	2.05e-05	0.00296	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	2.04e-05	0.00296	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GNS—peripheral nervous system neoplasm	2.02e-05	0.00292	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2e-05	0.00289	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.98e-05	0.00287	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.96e-05	0.00284	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NME1—peripheral nervous system neoplasm	1.93e-05	0.0028	CbGpPWpGaD
Bumetanide—CA14—Metabolism—BCHE—peripheral nervous system neoplasm	1.9e-05	0.00275	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ENO2—peripheral nervous system neoplasm	1.9e-05	0.00275	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	1.89e-05	0.00274	CbGpPWpGaD
Bumetanide—CA9—Metabolism—COX2—peripheral nervous system neoplasm	1.86e-05	0.0027	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—BCHE—peripheral nervous system neoplasm	1.85e-05	0.00268	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	1.82e-05	0.00264	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.81e-05	0.00263	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.8e-05	0.00261	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.79e-05	0.00259	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TH—peripheral nervous system neoplasm	1.79e-05	0.00259	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.78e-05	0.00258	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.00256	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TH—peripheral nervous system neoplasm	1.74e-05	0.00252	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—BCHE—peripheral nervous system neoplasm	1.73e-05	0.00251	CbGpPWpGaD
Bumetanide—CA7—Metabolism—BCHE—peripheral nervous system neoplasm	1.73e-05	0.00251	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.65e-05	0.00239	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.65e-05	0.00239	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.64e-05	0.00237	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TH—peripheral nervous system neoplasm	1.63e-05	0.00236	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TH—peripheral nervous system neoplasm	1.63e-05	0.00236	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	1.61e-05	0.00233	CbGpPWpGaD
Bumetanide—CA12—Metabolism—BCHE—peripheral nervous system neoplasm	1.6e-05	0.00232	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.6e-05	0.00231	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.59e-05	0.00231	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.59e-05	0.0023	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.57e-05	0.00227	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.57e-05	0.00227	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.53e-05	0.00221	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ENO2—peripheral nervous system neoplasm	1.51e-05	0.00219	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.51e-05	0.00219	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TH—peripheral nervous system neoplasm	1.51e-05	0.00218	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.48e-05	0.00214	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GNAS—peripheral nervous system neoplasm	1.46e-05	0.00211	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.45e-05	0.0021	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ABCB1—peripheral nervous system neoplasm	1.43e-05	0.00207	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-05	0.00206	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.42e-05	0.00206	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.00202	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.00194	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.34e-05	0.00194	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GNAS—peripheral nervous system neoplasm	1.33e-05	0.00192	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GNAS—peripheral nervous system neoplasm	1.33e-05	0.00192	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	1.32e-05	0.00192	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.3e-05	0.00189	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ABCB1—peripheral nervous system neoplasm	1.3e-05	0.00189	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.29e-05	0.00186	CbGpPWpGaD
Bumetanide—CA4—Metabolism—BCHE—peripheral nervous system neoplasm	1.28e-05	0.00185	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.28e-05	0.00185	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.26e-05	0.00183	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TH—peripheral nervous system neoplasm	1.26e-05	0.00182	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.23e-05	0.00179	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	1.23e-05	0.00179	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GNAS—peripheral nervous system neoplasm	1.23e-05	0.00178	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-05	0.00177	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.22e-05	0.00177	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.22e-05	0.00176	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ABCB1—peripheral nervous system neoplasm	1.21e-05	0.00175	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	1.2e-05	0.00174	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TH—peripheral nervous system neoplasm	1.2e-05	0.00174	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.19e-05	0.00173	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.19e-05	0.00172	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.08e-05	0.00156	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.08e-05	0.00156	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.00153	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—peripheral nervous system neoplasm	1.05e-05	0.00152	CbGpPWpGaD
Bumetanide—CA9—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-05	0.0015	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.03e-05	0.00149	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.02e-05	0.00147	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.00146	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.97e-06	0.00144	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.86e-06	0.00143	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GNAS—peripheral nervous system neoplasm	9.81e-06	0.00142	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TH—peripheral nervous system neoplasm	9.71e-06	0.00141	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	9.69e-06	0.0014	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ABCB1—peripheral nervous system neoplasm	9.63e-06	0.00139	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	9.4e-06	0.00136	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GNS—peripheral nervous system neoplasm	9.29e-06	0.00134	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.03e-06	0.00131	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.94e-06	0.00129	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.19e-06	0.00119	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GNAS—peripheral nervous system neoplasm	7.93e-06	0.00115	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	7.8e-06	0.00113	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCB1—peripheral nervous system neoplasm	7.78e-06	0.00113	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	7.78e-06	0.00113	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	7.72e-06	0.00112	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	7.46e-06	0.00108	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	7.18e-06	0.00104	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	6.59e-06	0.000955	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	6.5e-06	0.00094	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.4e-06	0.000926	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.29e-06	0.000911	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	6.2e-06	0.000897	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	5.63e-06	0.000815	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.25e-06	0.00076	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	5.06e-06	0.000733	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.97e-06	0.000719	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	4.71e-06	0.000682	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	4.54e-06	0.000657	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.44e-06	0.000642	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	3.98e-06	0.000576	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AKT1—peripheral nervous system neoplasm	3.94e-06	0.00057	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AKT1—peripheral nervous system neoplasm	3.84e-06	0.000556	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.8e-06	0.00055	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	3.74e-06	0.000542	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	3.59e-06	0.000519	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AKT1—peripheral nervous system neoplasm	3.59e-06	0.000519	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKT1—peripheral nervous system neoplasm	3.32e-06	0.000481	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	3.06e-06	0.000442	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	3e-06	0.000434	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.78e-06	0.000402	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKT1—peripheral nervous system neoplasm	2.65e-06	0.000383	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	2.54e-06	0.000367	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKT1—peripheral nervous system neoplasm	2.14e-06	0.00031	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	2e-06	0.00029	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	1.52e-06	0.000221	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—peripheral nervous system neoplasm	1.42e-06	0.000206	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.37e-06	0.000198	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	1.12e-06	0.000161	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	9.85e-07	0.000143	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	8.25e-07	0.000119	CbGpPWpGaD
